BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 22287300)

  • 1. Development of an internet-based cohort of patients with inflammatory bowel diseases (CCFA Partners): methodology and initial results.
    Long MD; Kappelman MD; Martin CF; Lewis JD; Mayer L; Kinneer PM; Sandler RS
    Inflamm Bowel Dis; 2012 Nov; 18(11):2099-106. PubMed ID: 22287300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Achieving Synergy: Linking an Internet-Based Inflammatory Bowel Disease Cohort to a Community-Based Inception Cohort and Multicentered Cohort in Inflammatory Bowel Disease.
    Kochar B; Aldridge M; Cook SF; Bright R; Mallette M; Moniz H; Shah SA; LeLeiko NS; Shapiro J; Sands BE; Chen W; Jaeger E; Galanko J; Long MD; Martin CF; Sandler RS; Kappelman MD
    J Med Internet Res; 2016 Jun; 18(6):e124. PubMed ID: 27261008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of an internet-based cohort of inflammatory bowel disease (CCFA partners).
    Randell RL; Long MD; Cook SF; Wrennall CE; Chen W; Martin CF; Anton K; Sandler RS; Kappelman MD
    Inflamm Bowel Dis; 2014 Mar; 20(3):541-4. PubMed ID: 24451221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sleep disturbance and risk of active disease in patients with Crohn's disease and ulcerative colitis.
    Ananthakrishnan AN; Long MD; Martin CF; Sandler RS; Kappelman MD
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):965-71. PubMed ID: 23376797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and Impact of Inflammatory Bowel Disease-Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners.
    Abdalla MI; Sandler RS; Kappelman MD; Martin CF; Chen W; Anton K; Long MD
    Inflamm Bowel Dis; 2017 Feb; 23(2):325-331. PubMed ID: 28092305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
    Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
    Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a Simple 0 to 10 Numerical Score (IBD-10) of Patient-reported Inflammatory Bowel Disease Activity for Routine Clinical Use.
    Subramanian S; Asher R; Weston W; Rimmer M; McConville A; Malin A; Jackson R; Collins P; Probert C; Dibb M; Rhodes JM
    Inflamm Bowel Dis; 2016 Aug; 22(8):1902-7. PubMed ID: 27243590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harnessing person-generated health data to accelerate patient-centered outcomes research: the Crohn's and Colitis Foundation of America PCORnet Patient Powered Research Network (CCFA Partners).
    Chung AE; Sandler RS; Long MD; Ahrens S; Burris JL; Martin CF; Anton K; Robb A; Caruso TP; Jaeger EL; Chen W; Clark M; Myers K; Dobes A; Kappelman MD
    J Am Med Inform Assoc; 2016 May; 23(3):485-90. PubMed ID: 26911821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial.
    Irvine EJ; Zhou Q; Thompson AK
    Am J Gastroenterol; 1996 Aug; 91(8):1571-8. PubMed ID: 8759664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: an online IBD registry.
    Bokemeyer B; Hardt J; Hüppe D; Prenzler A; Conrad S; Düffelmeyer M; Hartmann P; Hoffstadt M; Klugmann T; Schmidt C; Weismüller J; Mittendorf T; Raspe H
    J Crohns Colitis; 2013 Jun; 7(5):355-68. PubMed ID: 22503168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication Utilization and the Impact of Continued Corticosteroid Use on Patient-reported Outcomes in Older Patients with Inflammatory Bowel Disease.
    Geisz M; Ha C; Kappelman MD; Martin CF; Chen W; Anton K; Sandler RS; Long MD
    Inflamm Bowel Dis; 2016 Jun; 22(6):1435-41. PubMed ID: 26978725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Gastrointestinal Patient Reported Outcomes Measurement Information System (GI-PROMIS) Symptom Scales in Subjects With Inflammatory Bowel Diseases.
    Kochar B; Martin CF; Kappelman MD; Spiegel BM; Chen W; Sandler RS; Long MD
    Am J Gastroenterol; 2018 Jan; 113(1):72-79. PubMed ID: 28853727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the spanish version of the inflammatory bowel disease questionnaire on ulcerative colitis and Crohn's disease.
    López-Vivancos J; Casellas F; Badia X; Vilaseca J; Malagelada JR
    Digestion; 1999; 60(3):274-80. PubMed ID: 10343142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for depression in the elderly inflammatory bowel disease population.
    Long MD; Kappelman MD; Martin CF; Chen W; Anton K; Sandler RS
    J Crohns Colitis; 2014 Feb; 8(2):113-9. PubMed ID: 23932782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the patient-reported outcomes measurement information system in a large cohort of patients with inflammatory bowel diseases.
    Kappelman MD; Long MD; Martin C; DeWalt DA; Kinneer PM; Chen W; Lewis JD; Sandler RS
    Clin Gastroenterol Hepatol; 2014 Aug; 12(8):1315-23.e2. PubMed ID: 24183956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Nonsteroidal Anti-Inflammatory Drugs in Exacerbations of Inflammatory Bowel Disease.
    Long MD; Kappelman MD; Martin CF; Chen W; Anton K; Sandler RS
    J Clin Gastroenterol; 2016 Feb; 50(2):152-6. PubMed ID: 26485106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Out-of-pocket Cost Burden in Pediatric Inflammatory Bowel Disease: A Cross-sectional Cohort Analysis.
    Sin AT; Damman JL; Ziring DA; Gleghorn EE; Garcia-Careaga MG; Gugig RR; Hunter AK; Burgis JC; Bass DM; Park KT
    Inflamm Bowel Dis; 2015 Jun; 21(6):1368-77. PubMed ID: 25839776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with inflammatory bowel disease--an ECCO-EpiCom study.
    Burisch J; Weimers P; Pedersen N; Cukovic-Cavka S; Vucelic B; Kaimakliotis I; Duricova D; Bortlik M; Shonová O; Vind I; Avnstrøm S; Thorsgaard N; Krabbe S; Andersen V; Dahlerup JF; Kjeldsen J; Salupere R; Olsen J; Nielsen KR; Manninen P; Collin P; Katsanos KH; Tsianos EV; Ladefoged K; Lakatos L; Ragnarsson G; Björnsson E; Bailey Y; O'Morain C; Schwartz D; Odes S; Valpiani D; Boni MC; Jonaitis L; Kupcinskas L; Turcan S; Barros L; Magro F; Lazar D; Goldis A; Nikulina I; Belousova E; Fernandez A; Sanroman L; Almer S; Zhulina Y; Halfvarson J; Arebi N; Diggory T; Sebastian S; Lakatos PL; Langholz E; Munkholm P;
    J Crohns Colitis; 2014 Sep; 8(9):1030-42. PubMed ID: 24560877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of threatening life experiences and adverse family relations in ulcerative colitis: analysis using structural equation modeling and comparison with Crohn's disease.
    Slonim-Nevo V; Sarid O; Friger M; Schwartz D; Sergienko R; Pereg A; Vardi H; Singer T; Chernin E; Greenberg D; Odes S;
    Eur J Gastroenterol Hepatol; 2017 May; 29(5):577-586. PubMed ID: 28350749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.